標普和納斯達克內在價值 聯繫我們

Sartorius Stedim Biotech S.A. SRTOY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • FR • USD

SharesGrow Score
44/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sartorius Stedim Biotech S.A. (SRTOY) 是一家上市公司 屬於 醫療保健 板塊,經營於 Medical - Instruments & Supplies 產業. 公司總部位於 Aubagne, 法国. 現任CEO為 Rene Faber.

SRTOY 擁有 IPO日期為 2022-02-09, 9,961 名全職員工, 在 Other OTC, 市值為 $210.8B.

關於 Sartorius Stedim Biotech S.A.

Sartorius Stedim Biotech S.A. is a global supplier of instruments, consumables, and services for the biopharmaceutical industry. The company provides a comprehensive portfolio including cell lines, culture media, bioreactors, filtration and purification systems, and single-use bioprocess equipment, as well as data analytics software for optimizing biopharmaceutical development and production. It serves pharmaceutical manufacturers, research laboratories, and producers in the food and chemical industries with solutions spanning cell cultivation, fermentation, purification, and product storage and transportation. Founded in 1870 and headquartered in Aubagne, France, Sartorius Stedim Biotech operates as a subsidiary of Sartorius AG.

📍 Zone Industrielle Les Paluds, Aubagne 13781 📞 33 4 42 84 56 00
公司詳情
所屬板塊醫療保健
細分行業Medical - Instruments & Supplies
國家法国
交易所Other OTC
貨幣USD
IPO日期2022-02-09
首席執行官Rene Faber
員工數9,961
交易資訊
當前價格$21.67
市値$210.8B
52週區間17.395-26.54
Beta1.17
ETF
ADR
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值,發現被低估的股票。
每週線上課程
給我們留言